Pingfu Fu_crop

Pingfu Fu, PhD

Associate Professor

pxf16@case.edu | 216.368.3911 | School of Medicine, Wood Bldg. Rm. WG-82P

Education

Ph.D. 2001, Biostatistics; M.S. 1996, Statistics, Case Western Reserve University, Cleveland, Ohio
M.S. 1988, Mathematics, Xiangtan University, Xiangtan, Hunan, China
B.S. 1984, Mathematics, Jiangxi Normal University, Nanchang, Jiangxi, China

Personal Website: http://bfox.cwru.edu/~pxf

Research Interest

Survival analysis, study design, measurements with limits of detection, tree-based methods, problem of separation, clinical trials and novel applications of statistical methods to medical research, especially to cancer and HIV/AIDS.

Professional Memberships

American Statistical Association

Recent Publications

  1. Chiu, M, Lipka, MB, Bhateja, P, Fu, P, Dowlati, A. A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer. Transl Lung Cancer Res 2020; 9 (1): 55-60. PubMed PMID:32206553 PubMed Central PMC7082292.
  2. Bhargava, HK, Leo, P, Elliott, R, Janowczyk, A, Whitney, J, Gupta, S, Fu, P, Yamoah, K, Khani, F, Robinson, BD, Rebbeck, TR, Feldman, M, Lal, P, Madabhushi, A. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients. Clin. Cancer Res. 2020; : . PubMed PMID:32139401 .
  3. Vaidya, P, Bera, K, Gupta, A, Wang, X, Corredor, G, Fu, P, Beig, N, Prasanna, P, Patil, P, Velu, P, Rajiah, P, Gilkeson, R, Feldman, M, Choi, H, Velcheti, V, Madabhushi, A. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction. Lancet Digit Health 2020; 2 (3): e116-e128. PubMed PMID:32123864 PubMed Central PMC7051021.
  4. Shukla, S, Srivastava, JK, Shankar, E, Kanwal, R, Nawab, A, Sharma, H, Bhaskaran, N, Ponsky, LE, Fu, P, MacLennan, GT, Gupta, S. Oxidative Stress and Antioxidant Status in High-Risk Prostate Cancer Subjects. Diagnostics (Basel) 2020; 10 (3): . PubMed PMID:32120827 .
  5. Khorrami, M, Bera, K, Leo, P, Vaidya, P, Patil, P, Thawani, R, Velu, P, Rajiah, P, Alilou, M, Choi, H, Feldman, MD, Gilkeson, RC, Linden, P, Fu, P, Pass, H, Velcheti, V, Madabhushi, A. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study. Lung Cancer 2020; 142 : 90-97. PubMed PMID:32120229 .
  6. Khorrami, M, Khunger, M, Zagouras, A, Patil, P, Thawani, R, Bera, K, Rajiah, P, Fu, P, Velcheti, V, Madabhushi, A. Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma. Radiol Artif Intell 2019; 1 (2): e180012. PubMed PMID:32076657 PubMed Central PMC6515986.
  7. Zeng, G, Chen, Z, Fu, P. Temporal Pattern of Co-Development of Internalizing and Externalizing Problem Behaviors: An Application of Bivariate Mixed-Effects Models. Rev Recent Clin Trials 2020; 15 (1): 60-69. PubMed PMID:31746303 .
  8. Khorrami, M, Prasanna, P, Gupta, A, Patil, P, Velu, PD, Thawani, R, Corredor, G, Alilou, M, Bera, K, Fu, P, Feldman, M, Velcheti, V, Madabhushi, A. Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer. Cancer Immunol Res 2020; 8 (1): 108-119. PubMed PMID:31719058 .
  9. Khorrami, M, Jain, P, Bera, K, Alilou, M, Thawani, R, Patil, P, Ahmad, U, Murthy, S, Stephans, K, Fu, P, Velcheti, V, Madabhushi, A. Corrigendum to "Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features" [Lung Cancer 135 (September) (2019) 1-9]. Lung Cancer 2019; 136 : 156. PubMed PMID:31564290 .
  10. Khorrami, M, Jain, P, Bera, K, Alilou, M, Thawani, R, Patil, P, Ahmad, U, Murthy, S, Stephans, K, Fu, P, Velcheti, V, Madabhushi, A. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features. Lung Cancer 2019; 135 : 1-9. PubMed PMID:31446979 PubMed Central PMC6711393.
Search PubMed